Product Overview
CagriSema is a research peptide blend that combines Cagrilintide, a long-acting amylin analog, with Semaglutide, a GLP-1 receptor agonist. This dual-hormone combination is used in metabolic research to explore appetite control, delayed gastric emptying, caloric intake reduction, and weight regulation. Studies show that targeting both amylin and GLP-1 receptors may produce stronger effects than using either compound alone.
Key Areas of Research
- Obesity and metabolic disease models
- Synergy in appetite and satiety pathways
- Gastric motility and energy intake regulation
- Multi-receptor metabolic therapy strategies
Applications in Research
- Appetite and food intake studies
- Weight regulation models
- Receptor crosstalk and hormonal synergy
- Advanced multi-agonist metabolic pathway research
Storage and Handling
Store the lyophilized blend at minus 20°C in a dry and dark environment. Reconstitute with sterile bacteriostatic water to support laboratory use. After reconstitution, keep refrigerated and use within appropriate timeframes. Avoid repeated freeze and thaw cycles.




